184 related articles for article (PubMed ID: 34895050)
21. Isorhynchophylline enhances Nrf2 and inhibits MAPK pathway in cardiac hypertrophy.
Zhang Y; Cui Y; Dai S; Deng W; Wang H; Qin W; Yang H; Liu H; Yue J; Wu D; Wang J; Guo H
Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):203-212. PubMed ID: 31489470
[TBL] [Abstract][Full Text] [Related]
22. Paeoniflorin protects Schwann cells against high glucose induced oxidative injury by activating Nrf2/ARE pathway and inhibiting apoptosis.
Yang X; Yao W; Shi H; Liu H; Li Y; Gao Y; Liu R; Xu L
J Ethnopharmacol; 2016 Jun; 185():361-9. PubMed ID: 26979341
[TBL] [Abstract][Full Text] [Related]
23. Atrial natriuretic peptide protects vertebral endplate chondrocytes against H
He F; Gai J; Wang J; Tang L; Liu Y; Feng Q
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476501
[TBL] [Abstract][Full Text] [Related]
24. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy.
Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG
Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models.
Cheng KC; Li Y; Chang WT; Chen ZC; Cheng JT; Tsai CC
J Food Drug Anal; 2019 Jan; 27(1):355-364. PubMed ID: 30648591
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
Ji H; Qu J; Peng W; Yang L
Int Heart J; 2022; 63(3):602-611. PubMed ID: 35650160
[TBL] [Abstract][Full Text] [Related]
27. SIRT6 protects vascular endothelial cells from angiotensin II-induced apoptosis and oxidative stress by promoting the activation of Nrf2/ARE signaling.
Yang Y; Tian T; Wang Y; Li Z; Xing K; Tian G
Eur J Pharmacol; 2019 Sep; 859():172516. PubMed ID: 31265839
[TBL] [Abstract][Full Text] [Related]
28. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
29. Targeting of midkine alleviates cardiac hypertrophy via attenuation of oxidative stress and autophagy.
Shi Y; Ge J; Li R; Li Y; Lin L
Peptides; 2022 Jul; 153():170800. PubMed ID: 35427698
[TBL] [Abstract][Full Text] [Related]
30. L-Carnitine Reduces Myocardial Oxidative Stress and Alleviates Myocardial Ischemia-Reperfusion Injury by Activating Nuclear Transcription-Related Factor 2 (Nrf2)/Heme Oxygenase-1 (HO-1) Signaling Pathway.
Zhao T; Chen S; Wang B; Cai D
Med Sci Monit; 2020 May; 26():e923251. PubMed ID: 32452468
[TBL] [Abstract][Full Text] [Related]
31. G-protein coupled receptor 30 attenuates myocardial hypertrophy by reducing oxidative stress and apoptosis in Ang II-treated mice.
Wang Y; Xing Y; Liu X; Chen L; Zhang G; Li Y
Peptides; 2022 Nov; 157():170878. PubMed ID: 36108979
[TBL] [Abstract][Full Text] [Related]
32. Dexmedetomidine attenuates hypoxia-induced cardiomyocyte injury by promoting telomere/telomerase activity: Possible involvement of ERK1/2-Nrf2 signaling pathway.
Wu W; Du Z; Wu L
Cell Biol Int; 2022 Jul; 46(7):1036-1046. PubMed ID: 35312207
[TBL] [Abstract][Full Text] [Related]
33. Plantago asiatica L. seeds extract protects against cardiomyocyte injury in isoproterenol- induced cardiac hypertrophy by inhibiting excessive autophagy and apoptosis in mice.
Fan W; Zhang B; Wu C; Wu H; Wu J; Wu S; Zhang J; Yang X; Yang L; Hu Z; Wu X
Phytomedicine; 2021 Oct; 91():153681. PubMed ID: 34371252
[TBL] [Abstract][Full Text] [Related]
34. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
35. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis.
Ellmers LJ; Knowles JW; Kim HS; Smithies O; Maeda N; Cameron VA
Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H707-14. PubMed ID: 12124219
[TBL] [Abstract][Full Text] [Related]
36. Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway.
Li Y; Zhou WW; Sun JH; Yang HX; Xu GR; Zhang Y; Song QH; Zhang C; Liu WZ; Liu XC; Li AY
Biomed Pharmacother; 2021 Nov; 143():112178. PubMed ID: 34649308
[TBL] [Abstract][Full Text] [Related]
37. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
38. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
[TBL] [Abstract][Full Text] [Related]
39. Hydroxysafflor yellow A protects against angiotensin II‑induced hypertrophy.
Ni B; Zhou D; Jing Y; Liu S
Mol Med Rep; 2018 Oct; 18(4):3649-3656. PubMed ID: 30132539
[TBL] [Abstract][Full Text] [Related]
40. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
